| __timestamp | Bio-Techne Corporation | Novavax, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 30945000 | 79435000 |
| Thursday, January 1, 2015 | 40853000 | 162644000 |
| Friday, January 1, 2016 | 45187000 | 237939000 |
| Sunday, January 1, 2017 | 53514000 | 168435000 |
| Monday, January 1, 2018 | 55329000 | 173797000 |
| Tuesday, January 1, 2019 | 62413000 | 113842000 |
| Wednesday, January 1, 2020 | 65192000 | 747027000 |
| Friday, January 1, 2021 | 70603000 | 2534508000 |
| Saturday, January 1, 2022 | 87140000 | 1235278000 |
| Sunday, January 1, 2023 | 92493000 | 737502000 |
| Monday, January 1, 2024 | 96664000 |
Unleashing the power of data
In the ever-evolving landscape of biotechnology, innovation is the key to staying ahead. Bio-Techne Corporation and Novavax, Inc. have been at the forefront of this race, investing heavily in research and development (R&D) over the past decade. From 2014 to 2023, Bio-Techne's R&D expenses grew by approximately 212%, reflecting a steady commitment to innovation. In contrast, Novavax's R&D spending skyrocketed, peaking in 2021 with a staggering 2,534% increase from 2014, driven by the global demand for vaccines.
While Bio-Techne's investment has been consistent, Novavax's spending saw dramatic fluctuations, particularly during the COVID-19 pandemic. This highlights the company's strategic focus on vaccine development. However, data for 2024 is missing for Novavax, leaving a gap in the analysis. As these companies continue to prioritize innovation, their R&D investments will likely shape the future of biotechnology.
R&D Spending Showdown: AbbVie Inc. vs Bio-Techne Corporation
Research and Development Investment: Bristol-Myers Squibb Company vs Novavax, Inc.
Madrigal Pharmaceuticals, Inc. or Novavax, Inc.: Who Invests More in Innovation?
Alkermes plc vs Novavax, Inc.: Strategic Focus on R&D Spending
R&D Insights: How Catalyst Pharmaceuticals, Inc. and Novavax, Inc. Allocate Funds
Analyzing R&D Budgets: ImmunityBio, Inc. vs Novavax, Inc.
Supernus Pharmaceuticals, Inc. or Novavax, Inc.: Who Invests More in Innovation?
MannKind Corporation or Novavax, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Celldex Therapeutics, Inc. vs Novavax, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Evotec SE and Novavax, Inc.
Comparing Innovation Spending: Xencor, Inc. and Novavax, Inc.
Novavax, Inc. vs Viridian Therapeutics, Inc.: Strategic Focus on R&D Spending